Interleukin-33 induces interleukin-17F in bronchial epithelial cells

Area of Science:

• Immunology
• Cell Biology
• Respiratory Medicine

Background:

• Asthma pathogenesis involves Interleukin-33 (IL-33) and Interleukin-17F (IL-17F), but their precise roles and regulatory mechanisms remain unclear.
• IL-33 is notably expressed in the airways of asthma patients, highlighting its potential significance.

Purpose of the Study:

• To investigate the role of IL-33 in regulating IL-17F expression in bronchial epithelial cells.
• To elucidate the specific signaling pathways mediating IL-33-induced IL-17F production.

Main Methods:

• Bronchial epithelial cells were stimulated with IL-33, and IL-17F expression was quantified using real-time PCR and ELISA.
• Signaling pathway components, including ST2, MAP kinases (ERK1/2, p38MAPK, JNK), and MSK1, were analyzed via Western blot.
• Inhibitors of kinases and ST2, along with siRNA targeting MSK1, were employed to dissect the signaling cascade.

Main Results:

• IL-33 significantly upregulated both IL-17F gene and protein expression in bronchial epithelial cells.
• IL-33-induced IL-17F production was dependent on the IL-33 receptor ST2 and involved the phosphorylation of ERK1/2 and MSK1.
• Inhibition of MEK, MSK1, or ST2 effectively blocked IL-17F expression, confirming the ST2-ERK1/2-MSK1 pathway.

Conclusions:

• IL-33 stimulates IL-17F expression in bronchial epithelial cells through the ST2-ERK1/2-MSK1 signaling pathway.
• The IL-33/IL-17F axis represents a potential therapeutic target for managing allergic airway inflammation in asthma.